Innovative Testing Solutions
By combining our precise, rapid, microbial identification technology with a deep understanding of the unique challenges faced by those with cystic fibrosis, we aim to enhance the quality of life for patients and contribute to a future where early, accurate microbial identification becomes a cornerstone in the management of this complex condition.
Our Mission
Our work will revolutionise healthcare for individuals with cystic fibrosis and broader respiratory infection by providing precise and rapid microbial identification enabling timely and targeted interventions. Our dedication to excellence, scientific integrity and compassionate care drives us to push boundaries, ultimately transforming the landscape of cystic fibrosis healthcare and bringing hope to individuals and their families worldwide.
Our goal is to provide accurate and timely diagnostic solutions for microbial infections, improving patient outcomes and quality of life in various healthcare settings
Infectious Disease Testing
Early Diagnosis
Management of Exacerbation
Cessation of long term inhaled antibiotics
Non-invasive
Our Leadership
Our strength lies in our innovative ability, multidisciplinary approach and inclusion of healthcare professionals from the get go. The team strives to bring in the best talent to deliver our goals.
Dr Simone Lucanto
CTO
Hayden Jeffreys
Chairman
Dr Amanda Larkin
CFO
Dr James Duncan
Board Observer, University of NOttingham
Dr Rachel Shelmerdine
CEO
Scientific Advisory Board
Our leadership is supported by leading scientific, industry and clinical experts who provide expert guidance on scientific, technical and clinical matters to validate and progress our technical development.
Dr Helen Barr
cmo
Professor Luisa Martinez-Pomares
Scientific adviser - antibody expert
Emeritus Professor Miguel Cámara
sCIENTIFIC ADVISER - quorum sensing biomarker expert
Dr Simon Flint
regulatory & quality LEAD
